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Abstract
Background: The optimal blood pressure (BP) treatment target is still being debated, specifically di-
astolic BP (DBP) in patients with obstructive coronary artery disease (CAD); a DBP which is too low 
could compromise myocardial perfusion and is associated with adverse outcomes. 
Methods: This study examined the relationship between DBP levels and the severity and atheroscle-
rotic burden of CAD in 231 consecutive stable patients with evidence of obstructive CAD as detected by 
elective coronary angiography. The SYNTAX (Synergy Between Percutaneous Coronary Intervention 
With Taxus and Cardiac Surgery) Score and SYNTAX Score II were used to quantify the atherosclerotic 
burden. 
Results: The patients were male (71%), median age 62, interquartile range [IQR] of 57 to 67,  and 84% 
had hypertension. The median DBP was 71.0 mmHg (IQR: 61 to 80) and the median SYNTAX Score was 
16.0 (IQR 9.0–23.0). DBP levels were inversely correlated with SYNTAX Score (r = –0.61) and SYNTAX 
Score II (r = –0.73). Adjusting for traditional risk factors, unprotected left main CAD, systolic BP, renal 
function, and medications, DBP levels remained independently inversely associated with a higher tertile 
of SYNTAX Score (adjusted odds ratio [OR] 0.89; 95% confidence interval [CI] 0.85–0.92, p < 0.001) 
and SYNTAX Score II (adjusted OR 0.75; 95% CI 0.69–0.80, p < 0.001). The frequency of high athero-
sclerotic burden identified by the presence of intermediate or high SYNTAX Score and SYNTAX Score II  
was significantly higher among patients with a DBP < 60 mmHg.
Conclusions: Low DBP levels are independently associated with high SYNTAX Score and SYNTAX 
Score II in stable patients with obstructive CAD. (Cardiol J 2018; 25, 3: 345–352)
Key words: hypertension, diastolic blood pressure, coronary artery disease, J-curve 
phenomenon, SYNTAX Score, atherosclerosis 
Introduction
The prevalence of hypertension, a common 
risk of cardiovascular disease (CVD), has been in-
creasing and remains the leading cause of CVD and 
death worldwide [1, 2]. Lowering blood pressure 
(BP) reduces the risk of CVD and death [3], but 
the optimal BP target has been extensively debated 
[4, 5]. Recently, a SPRINT (Systolic Blood pres-
sure Intervention Trial) [6] showed that intensive 
systolic BP (SBP) ≤ 120 mmHg among high-risk 
patients was associated with a reduction in the 
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primary outcomes (stroke, myocardial infarction 
[MI], non-MI acute coronary syndrome, heart fail-
ure and cardiovascular [CV] death), and all-cause 
deaths. There is a potential concern, however, that 
intensive BP reduction is particularly related to CV 
events due to a J-curve phenomenon [7]. Because 
SBP reduction also lowers diastolic BP (DBP) and 
coronary blood flow during diastole; therefore, low 
DBP might compromise coronary perfusion pres-
sure and result in associated myocardial ischemia 
and damage, especially in patients with obstructive 
coronary artery disease (CAD) [8, 9]. 
Recently, exciting new data reported by Mc-
Evoy et al. [10] showed that low DBP, particularly 
among patients with DBP < 60 mmHg had a higher 
prevalence of subclinical myocardial damage (quan-
tified by high-sensitivity cardiac troponin T [hs-
-cTnT]) and was associated with CAD incidents and 
mortality. Furthermore, results from a recent study 
have shown that patients with hypertension and 
stable CAD and DBP < 70 mmHg were associated 
with an increased risk of CV events [11], which 
supports the existence of the J-curve phenomenon. 
Therefore, the relationship between a drop in DBP 
and myocardial damage and adverse CV outcomes 
may be associated with severity or complexity of 
diseased coronary vessels. A relationship, however, 
between DBP level and detailed characterization 
and quantification of the atherosclerotic burden has 
not been investigated.
The SYNergy between percutaneous coronary 
intervention with TAXus and cardiac surgery 
(SYNTAX) trials have shown that SYNTAX Score 
is an anatomical angiographic scoring system 
used to determine the complexity and burden of 
atherosclerotic CAD [12, 13]. The SYNTAX Score 
has been shown to predict major adverse cardiac 
events (MACE) and long term prognostic risk 
among patients with stable CAD who underwent 
coronary revascularization by coronary artery 
bypass graft surgery (CABG) and percutaneous 
coronary intervention (PCI) [14, 15]. The lack of 
clinical variables and purely anatomical focus of 
consideration, however, are major limitations of 
the SYNTAX Score. Subsequently, the SYNTAX 
Score II was recently developed. This consists of 
a combination of two anatomical (anatomical SYN-
TAX Scores and unprotected left main CAD) and 
6 clinical variables (age, creatinine clearance, left 
ventricular ejection fraction [LVEF], sex, chronic 
obstructive pulmonary disease, and peripheral 
artery disease). The SYNTAX Score II has shown 
better long-term (4-year) mortality predictions be-
tween CABG and PCI than the original anatomical 
SYNTAX Score [16]. As such, both the SYNTAX 
Score and SYNTAX Score II may provide  insight 
into understanding whether a lower DBP level, is 
associated with myocardial damage and adverse 
CV outcomes. 
In this prospective cross-sectional study, 
the relationship between DBP and severity and 
burden of coronary artery atherosclerotic lesions 
quantified by SYNTAX Score and SYNTAX Score II 
was sought.
Methods
Study population
This single-center cross-sectional study was 
approved by the Khon Kaen University Ethics Com-
mittee in Human Research (HE510414) and was con-
ducted in accordance with the Declaration of Helsinki. 
All participants provided informed, written consent. 
Adult subjects (aged ≥ 20 years) with signs or symp-
toms of CAD who underwent elective, non-urgent 
coronary angiography in the absence of emergency 
conditions were included at the Queen Sirikit Heart 
Center of the Northeast, Department of Medicine, 
Faculty of Medicine, Khon Kaen University, Thailand 
between 2008 and 2012. Patients who had experienced 
acute coronary syndrome or revascularization proce-
dures within 30 days prior to enrollment, or CABG, or 
PCI, had a LVEF < 40% and patients who had no evi-
dence of significant CAD were specifically excluded 
(total exclusion: 168 patients) (Fig. 1). Therefore, 
a total of 231 consecutive patients were included in 
this study.
Angiographic analysis
Images of diagnostic coronary angiograms 
were obtained with the Xcelera cardiology image 
management system (Philips, Netherlands) and 
each coronary lesion with evidence of significant 
stenosis in vessels of 1.5 mm or more were scored. 
Significant CAD was defined by diameter stenosis 
of 50% or more in at least one epicardial coronary 
artery based on the American College of Cardi-
ology Foundation and American Heart Associa-
tion guidelines [17, 18]. The SYNTAX Score and 
SYNTAX Score II were calculated for each patient 
using a computer program consisting of sequential 
and interactive self-guided questions according to 
the SYNTAX Score calculator version 2.28, and 
divided into tertiles, according to the STNTAX 
trial, which were defined as low (0–22), interme-
diate (23–32), and high (≥ 33) SYNTAX Score. 
The SYNTAX Score II was stratified according to 
tertiles of SYNTAX Score II for PCI as previously 
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described [19]. All angiograms were reviewed by 
the board-certified interventional cardiologist who 
was blinded to DBP and variable clinical data.
Laboratory testing and BP measurement
After informed consent was obtained from all 
patients, blood samples were collected after 12-h 
overnight fasting before catheterization proce-
dures, and was sent for analysis within 3 h of col-
lection. Analysis of routine biochemical markers 
were performed on samples using the Hitachi 917 
automatic analyzer (Roche Diagnostics, Basel, 
Switzerland). An estimated glomerular filtration 
rate (eGFR [mL/min/1.73 m2]) was calculated 
using the Modification of Diet in Renal Disease 
equation.
Blood pressure was measured in the left arm 
after the patient was resting supine for 15 min 
in a quiet room in an inpatient care unit, using 
a digital automatic sphygmomanometer (DINAMAP 
CARESCAPE V100, GE Medical Systems, WI, USA). 
Hypertension was defined as SBP ≥ 140 mmHg, DBP 
≥ 90 mmHg, a history of hypertension or the use 
of antihypertensive medications.
Statistical analysis
Descriptive statistics were used to calculate 
baseline characteristics of all eligible patients. 
Patients were divided into three groups according 
to the SYNTAX Score as low, intermediate, and 
high. Studied variables of all three groups were 
compared by one-way analysis of variance or the 
Kruskal-Wallis test or c2 or Fisher Exact test where 
appropriate. Spearman correlation analysis was 
used to examine the associations between DBP and 
SYNTAX Score, and SYNTAX Score II. An ordinal 
logistic regression analysis was adjusted for tradi-
tional risk factors (including age, sex, body mass in-
dex [BMI], hypertension, diabetes mellitus, smok-
ing, low-density lipoprotein cholesterol (LDL-C), 
high-density lipoprotein cholesterol (HDL-C), 
and triglycerides), SBP, eGFR, LVEF and medi-
cations (statins, angiotensin converting enzyme 
inhibitors [ACEI] or angiotensin receptor blocker 
[ARB], aspirin, and beta-blocker) were employed 
to examine the relationship of DBP and the higher 
SYNTAX Score and SYNTAX Score II. All analyses 
were performed used STATA version10.1 (STATA 
Corp., College Station, Tx, USA). A p < 0.05 
was considered statistically significant.
Results
The baseline characteristics of this study are 
provided in Table 1. Overall, the median age of the 
patients involved in this study was 62 years; 70% 
Figure 1. Consolidated Standards of Reporting Trials (CONSORT) diagram; CAD — coronary artery disease.
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were men, 27% had diabetes, 84% had hyperten-
sion, and the median BMI was 24.5 kg/m2. The 
median DBP was 71.0 mmHg (interquartile range 
[IQR] 61–80 mmHg), median SBP was 129.0 mmHg 
(IQR 120–142 mmHg) and the median LVEF was 
55% (45–62). The medians of the SYNTAX Score 
were 16.0 (IQR 9.0–23.0), and 165 (71%), 40 (17%) 
and 26 (12%) patients had low (0–22), intermedi-
ate (23–32), and high (≥ 33) SYNTAX Score. The 
medians of the SYNTAX Score II were 13.0 (IQR 
10.0–19.0) and 178 (77%), 19 (8%) and 34 (15%) 
patients had low (≤ 21), intermediate (> 21 and 
≤ 28), and high (> 28) SYNTAX Score II. Patients 
with a higher SYNTAX Score were more likely to 
have an unprotected left main CAD and tended to 
have a decreased SBP. Histories of smoking, sex, 
age, BMI, diabetes and hypertension were similar 
across SYNTAX Score tertiles. DBP was significant-
ly lower with an increased SYNTAX Score (Fig. 2A) 
and SYNTAX Score II tertiles (Fig. 2B).
Associations between DBP and SYNTAX 
Score and SYNTAX Score II
Diastolic BP levels were strongly inversely cor-
related with both SYNTAX Score and SYNTAX 
Score II (Spearman correlation; r = –0.61, and –0.73, 
both p < 0.0001). Following ordinal logistic regression 
analysis adjusting for traditional risk factors (including 
age, sex, BMI, hypertension, diabetes mellitus, smo-
king, LDL-C, HDL-C, and triglycerides), SBP, eGFR, 
LVEF and medications including statins, ACEI or ARB, 
aspirin, and beta-blockers, DBP levels remained inde-
pendently inversely associated with a higher tertile of 
SYNTAX Score (adjusted odds ratio [OR] 0.89; 95% 
confidence interval [CI] 0.85–0.92, p < 0.001) and 
SYNTAX Score II (adjusted OR 0.75; 95% CI 0.69–0.80, 
p < 0.001) (Table 2).
DBP and high atherosclerotic burden
High atherosclerotic burdens were identified 
by the presence of intermediate or high SYNTAX 
Table 1. Baseline characteristics of study patients.
Variables SYNTAX Score P
Total  
(n = 231)
Low  
(0–22, n = 165)
Intermediate  
(23–32, n = 40)
High  
(≥ 33, n = 26)
Age [year] 62 (57–67) 62 (56–67) 63 (58–67) 63 (58–71) 0.42
Men 69.3% 69.7% 67.5% 69.2% 0.96
Body mass index [kg/m2] 24.49 (22.6–26.7) 24.4 (22.5–26.9) 24.7 (22.5–26.5) 24.7 (23.3–26.2) 0.95
Systolic BP [mmHg] 129 (120–142) 130 (120–144) 129 (119.5–143) 124 (116–130) 0.09
Diastolic BP [mmHg] 71.0 (61–80) 74 (67–82) 61.5 (55–69.5) 58.5 (55–64) < 0.001
Left ventricular  
ejection fraction
55% (45–62) 53% (46–60) 55% (50–60) 56% (52–64) 0.11
Diabetes mellitus 27.0% 29.4% 27.3% 15.5% 0.22
Hypertension 84.4% 80% 82.5% 80.8% 0.77
Current smoker 42.4% 43.6% 50% 23.1% 0.08
Unprotected left main CAD 22.1% 12.7% 45% 46.2% < 0.01
LDL-C [mg/dL] 96.5 (72.5–124) 93 (71.5–117.5) 113 (77–141) 86 (70–132) 0.056
HDL-C [mg/dL] 39 (31–45) 37 (31–44) 39 (31–46) 40.5 (28–48) 0.85
Triglyceride [mg/dL] 162.5 (117–226) 158 (118.5–220) 178.5 (121–265) 161.5 (88–240) 0.53
eGFR [mL/min/1.73 m2] 71.5 (55–92) 71.8 (53.8–93.3) 72.8 (57.7–89) 70.4 (59–85.4) 0.92
Medication:
Aspirin 94.4% 97.5% 97.5% 84.6% 0.06
ACEI or ARB 28.8% 29.5% 25% 30.8% 0.83
Statin 76.9% 77.4% 80% 69.2% 0.57
Beta-blocker 55.9% 55.8% 55% 57.7% 0.97
ACEI or ARB — angiotensin-converting enzyme inhibitors or angiotensin receptor blocker; BP — blood pressure; CAD — coronary artery dis-
ease; eGFR — estimated glomerular filtration rate; HDL-C — high-density lipoprotein cholesterol; LDL-C — low-density lipoprotein cholesterol
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Score and SYNTAX Score II scores. The frequency 
of high atherosclerotic burden was significantly in-
creased with decreasing DBP, for SYNTAX Scores of 
69%, 36%, 16% and 3% in DBP < 60, 60–69, 70–79, 
and ≥ 80 mmHg; p<0.0001 for all (Fig. 3A) and 
SYNTAX Score II levels of 67%, 30.4%, 5.8% and 
1.7% in DBP < 60, 60–69, 70–79, and ≥ 80 mmHg; 
p < 0.0001 for all (Fig. 3B). 
Discussion
This study demonstrates the strongly signifi-
cant inverse association between DBP levels and 
coronary artery atherosclerotic burden quantified 
by the SYNTAX Score and SYNTAX Score II in 
stable patients with obstructive CAD. Further-
more, lower DBP levels were found to serve as 
an independent predictor of higher SYNTAX Score 
and SYNTAX Score II, even after adjustment for 
traditional risk factors, i.e. unprotected left main 
CAD, SBP, eGFR, and medications. Addition-
ally, the frequency of high atherosclerotic burden 
identified by the presence of an intermediate or 
high SYNTAX Score and SYNTAX Score II was 
significantly increased with a decreasing of DBP. 
Taken together, the present findings further dem-
onstrates that the low DBP levels are associated 
with a greater atherosclerotic burden.
Randomized data regarding the optimal BP 
target are still being debated, in particular, the most 
recent data from SPRINT showed that more-inten-
sive is better than less-intensive antihypertensive 
treatment [6]. There is a potential concern, how-
ever, for a J-curve phenomenon that is related to ad-
verse cardiac events, especially regarding DBP in 
CAD patients [7, 8]. Low DBP has previously been 
shown to possibily promote myocardial ischemia 
and subclinical myocardial damage [10]. Moreover, 
specifically in patients with stable CAD and with 
hypertension, a low DBP (< 70 mm Hg) was associ-
Figure 2. Relationship between diastolic blood pressure and measure of atherosclerotic burden. Lower diastolic blood 
pressure (BP) levels were associated with an increased SYNTAX Score (Anatomical) (A), SYNTAX Score II (B); PCI — 
percutaneous coronary intervention.
Table 2. Lower diastolic blood pressure is associated with increased likelihood of higher SYNTAX 
Score and SYNTAX Score II.
Variable SYNTAX Score SYNTAX Score II
OR (95% CI) P OR (95% CI) P 
Unadjusted 0.88 (0.87–0.93) < 0.001 0.79 (0.75–0.83) < 0.001
Adjusted 0.89 (0.85–0.92) < 0.001 0.75 (0.69–0.80) < 0.001
Adjusted for age, sex, body mass index, triglyceride, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, diabetes mel-
litus, hypertension, systolic blood pressure, smoking, estimated glomerular filtration rate, left ventricular ejection fraction and medications 
(statins, angiotensin-converting enzyme inhibitors or angiotensin receptor blocker, aspirin, and beta-blocker); CI — confidence interval;  
OR — odds ratio 
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ated with adverse CV outcomes [11]. The present 
study extends these findings by demonstrating 
a strongly independent association between low DBP 
and high atherosclerotic burden. Thus, the results 
are consistent that intensive reduction in DBP 
would be expected to decrease coronary perfusion 
pressure that would be associated with subclinical 
myocardial damage, which may be mechanistically 
linked with the development of high severity of an 
atherosclerotic burden of coronary vessels.
The SYNTAX Score is a useful tool to stratify 
risk outcomes in stable patients with complex 
CAD who have undergone revascularization by 
PCI or CABG [14, 15]. A high SYNTAX Score is 
correlated with a poor prognosis, which is also 
a marker of systemic atherosclerotic burden [12, 
13]. Furthermore, the SYNTAX Score II, which 
combines anatomical and clinical factors, has been 
shown to be a better long-term predictor of CV 
events and all-cause mortality [16]. In the present 
study, DBP was inversely correlated with both the 
SYNTAX Score and SYNTAX Score II. Importantly, 
the frequency of high atherosclerotic burden was 
significantly highest among patients with a DBP 
< 60 mm Hg in both the SYNTAX Score and 
SYNTAX Score II. Interestingly, these data are 
consistent with findings from recent studies that 
DBP < 60 mmHg was strongly associated with 
both subclinical myocardial damage and adverse 
CV events [10, 11]. Therefore, the current findings 
provided additional support that over-treatment 
of hypertension in patients with obstructive CAD 
may reduce coronary perfusion flow and precipitate 
myocardial damage that facilitates the development 
of coronary artery atherosclerotic burdens.
The results of the SPRINT hypothesis seems 
unlikely to be at odds with the J-curve hypothesis. 
In contrast, a HOPE-3 (Heart Outcomes Preven-
tion Evaluation) [20] trial reported that BP-lower-
ing therapy among intermediate patients at risk 
for CV with baseline SBP levels < 130 mmHg and 
a new meta-analysis [21] showed that among pa-
tients with diabetes an SBP less than 140 mmHg, 
BP-lowering therapy was not beneficial, but 
tended to cause harm. The results from SPRINT, 
however, should be interpreted with caution due 
to the method of BP measurement that used 
automatic oscillometric monitors after the pa-
tients were seated quietly alone and tended to 
be lower than traditional office BP measurement 
methods [22].
Based on these findings, it is thus conceivable 
that potentially severe atherosclerotic burdens of 
coronary artery vessels may occur in the setting 
of lowering of DBP. Importantly, the results are 
reasonable to apply to patients with hypertension 
and obstructive CAD in that the DBP treatment tar-
get should be less aggressive. This was, however, 
a hypothesis-generated study and further studies 
into the mechanisms of low DBP leading to an ath-
erosclerotic burden in patients with hypertension 
and obstructive CAD are warranted. 
Figure 3. Diastolic blood pressure and atherosclerotic burden. The frequency of high atherosclerotic burden according 
to (A) SYNTAX Score and (B) SYNTAX Score II when compared to the diastolic blood pressure level.
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Limitations of the study
This study was in a single tertiary care center 
study that recruited patients at the time of car-
diac evaluation for coronary angiography. There-
fore, it cannot exclude the presence of a selection 
bias for the patients undergoing evaluation and 
treatment for CAD. Second, because BP levels 
were measured at only a single point in time using 
a digital automatic sphygmomanometer after the 
patients had rested in a supine position for 15 min 
in a quiet room of an inpatient unit, pressures then 
may be similar or slightly lower than the traditional 
office BP measurement method. The lack of 24-h 
ambulatory BP measurement was also a limitation 
of this study. Third, complete information that may 
be associated with the atherosclerotic burden such 
as hs-cTnT or central aortic pressure or stiffness 
were lacking. Therefore, this study was not able to 
exclude other reasons as to whether the association 
between low DBP and atherosclerotic burden was 
due to subclinical myocardial damage, from low DBP, 
from central aortic stiffness or from a combination of 
reasons.Furthermore, there was a lack of complete 
information regarding the history of heart failure and 
MI; this issue was addressed by enrolling patients 
who were stable without requiring emergency care. 
Fourth, intravascular ultrasound or optical coherence 
tomography to evaluate the stenotic diameters or 
plaque characteristics were not available. Finally, the 
relatively low number of the patients in both the inter-
mediate and high SYNTAX Score and SYNTAX Score 
II tertiles was also a limitation of this study cohort.
Conclusions
A low DBP level had an independent associa-
tion with high SYNTAX Score and SYNTAX Score 
II. Lower DBP, particularly < 60 mmHg, may be 
important to recognize a potential pathophysiologi-
cal contribution of too low DBP in the development 
of complexity and an increased atherosclerotic 
burden, which is identified by the presence of in-
termediate or high SYNTAX Score and SYNTAX 
Score II in stable patients with obstructive CAD. 
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